Orthogon Therapeutics raises $11M in a funding round for its BK virus antiviral drug program, bringing total funding to $36M.
Amount Raised
$11 Million
Round Type
Funding Round
CantonInformation TechnologyBiotechnologyHealth CareScience And EngineeringDescription
Orthogon Therapeutics has completed a follow-on financing of $11 million to further advance its first-in-class drug against BK polyomavirus. This funding aims to support the development of an innovative oral therapy targeting viral proteins. BK virus infections are particularly problematic for transplant patients, where approved treatments are lacking. The new funding will help to address these urgent clinical needs.
Quick answer
Orthogon Therapeutics raised $11 Million in a Funding Round round, dated April 17, 2026. Orthogon Therapeutics is based in Canton, Massachusetts, United States.
- How much did Orthogon Therapeutics raise?
- Orthogon Therapeutics raised $11 Million in a Funding Round round on April 17, 2026.
- What does Orthogon Therapeutics do?
- Orthogon Therapeutics is a privately held R&D company.
- Where is Orthogon Therapeutics based and how big is it?
- Orthogon Therapeutics is based in Canton, Massachusetts, United States. Fundz records about 3 employees.
- Who are the decision-makers at Orthogon Therapeutics?
- Fundz holds 2 contacts at Orthogon Therapeutics, including the Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Orthogon Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Psilera raised $8.8M (Seed) on May 28, 2026.
- Degron Therapeutics raised $40M (Series A) on May 14, 2026.
- Maze Therapeutics raised $145M (Post-IPO Equity) on April 22, 2026.
- Ray Therapeutics raised $125M (Series B) on April 21, 2026.
- Enveric Biosciences raised $5M on April 17, 2026.
- Athos Therapeutics, Inc. raised $10M on April 17, 2026.
Who to call at Orthogon Therapeutics, and when
A new round usually means Orthogon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orthogon Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orthogon Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orthogon Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orthogon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Orthogon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.